Viewing Study NCT05017103


Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2025-12-28 @ 8:20 PM
Study NCT ID: NCT05017103
Status: TERMINATED
Last Update Posted: 2024-12-11
First Post: 2021-08-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sintilimab for the Treatment of Locally Advanced, Metastatic, Recurrent, or Unresectable Undifferentiated Pleomorphic Sarcoma, SiARa Cancer Study
Sponsor: M.D. Anderson Cancer Center
Organization: